Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Insulet Corporation is one of them.

Canaccord Genuity Raises Price Target on Insulet Corporation (PODD) to $399, Maintains Buy Rating

With significant upside potential, Insulet Corporation (NASDAQ:PODD) secures a spot on our list of the 13 Best Quality Stocks ...

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Medical Design & Outsourcing

How ViCentra built the smaller, more precise Kaleido insulin patch pump

ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...

A Glimpse Into The Expert Outlook On Insulet Through 6 Analysts

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...
Yahoo Finance

Insulet Corporation (PODD)

After hours: 2 October at 5:39:53 pm GMT-4 Chart does not reflect overnight price.